Ikarian Capital’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18.7M Buy
283,572
+110,900
+64% +$7.05M 2.67% 16
2025
Q4
$11M Sell
172,672
-50,002
-22% -$3.11M 1.42% 33
2025
Q3
$12.2M Sell
222,674
-10,790
-5% -$445K 2.48% 18
2025
Q2
$7.71M Buy
233,464
+83,482
+56% +$2.9M 2.55% 23
2025
Q1
$6.03M Hold
149,982
1.96% 30
2024
Q4
$7.06M Sell
149,982
-20,165
-12% -$1.05M 2.01% 28
2024
Q3
$8.98M Hold
170,147
2.79% 21
2024
Q2
$9.22M Buy
170,147
+25,000
+17% +$1.51M 2.88% 18
2024
Q1
$10.2M Buy
145,147
+115,147
+384% +$8.91M 2.77% 28
2023
Q4
$2.5M Buy
+30,000
New +$1.09M 0.69% 81
2023
Q3
Hold
0
163
2023
Q2
Sell
-55,666
Closed -$1.96M 149
2023
Q1
$1.96M Buy
+55,666
New +$2.27M 0.81% 58
2021
Q3
Sell
-120,895
Closed -$2.39M 239
2021
Q2
$2.39M Sell
120,895
-6,105
-5% -$143K 0.43% 120
2021
Q1
$2.95M Sell
127,000
-100,000
-44% -$2.14M 0.44% 173
2020
Q4
$4.72M Buy
227,000
+172,000
+313% +$3.14M 0.86% 98
2020
Q3
$1.19M Buy
+55,000
New +$1.29M 0.33% 126
2020
Q2
Hold
0
195
2020
Q1
Hold
0
175

Other funds holding CYTK